Shurong Zhang - Publications

Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Journal: Cancer medicine

Published: November 10, 2025

Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody.

Journal: Cancer letters

Published: December 11, 2024

Neoadjuvant immunochemotherapy in locally advanced laryngeal cancer and hypopharyngeal cancer: higher objective response rate and organ-preservation rate.

Journal: Investigational new drugs

Published: May 31, 2024

Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial.

Journal: Nature medicine

Published: January 25, 2024

The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal malignant tumors.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: August 12, 2023

Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized clinical trials.

Journal: Cancer medicine

Published: August 08, 2023

Induction chemotherapy-based organ-preservation protocol improve the function preservation compared with immediate total laryngectomy for locally advanced hypopharyngeal cancer-Results of a matched-pair analysis.

Journal: Cancer medicine

Published: March 20, 2023

The role of ADC value and Ki-67 index in predicting the response to neoadjuvant chemotherapy in advanced stages of olfactory neuroblastoma.

Journal: The British journal of radiology

Published: October 14, 2022

Expression of TRIM44 and its correlation with TLR4 in laryngeal squamous cell carcinoma.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: May 06, 2022

Retinoic Acid-Induced 2 (RAI2) Is a Novel Antagonist of Wnt/β-Catenin Signaling Pathway and Potential Biomarker of Chemosensitivity in Colorectal Cancer.

Journal: Frontiers in oncology

Published: October 30, 2021

Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.

Journal: World neurosurgery

Published: March 04, 2021

Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: April 13, 2016